AbstractThe narrative is based on the study of annual reports of Cipla reclaim and cheerfulness Pharmaceutical Industries restrain for the five years from 2003-2004 to 2007-2008. The chief(prenominal) objective of this study was to feed the concepts learned as a part of this course and go through the business, m unitarytary health and the consider practices followed by these companies. As a part of this report we contend tried to analyze the latest and gone slaying trends for the troupe and predict the future performance and stock prices of the union. To achieve this we finagle analyzed Revenue Trends, Profitability, Liquidity, Debts, Stocks, exchange Flows and provided a summary at the end of the report. The scope of the report is limited to our understanding of the pecuniary Statements based on the modern course. The report has to be seen in its completeness along with the excel worksheet containing the yesteryear five years pecuniary data of the two firms and motley ratios. IntroductionCipla is a leading pharmaceutic company in India and it is one of the largest exporters of drugs from India with exports contributing around 50% of its annual revenues. It offers a blanket(prenominal) range of products ranging from anti-asthma, cardiac to faultfinding care drugs. Over the past 3 years the domesticated revenue has grown at a rate of 12% and the export revenue at 27% .
Sun Pharmaceuticals is a Mumbai based multinational company employing over 8,000 people and manufacturing facilities in 19 countries. It specializes in degenerative ailment drugs and has been consistently arm market share in India. The recent acquisitions of Caraco Pharm has helped Sun to fox up its global presence. Cipla and Sun Pharmaceuticals are comparable companies in harm of revenues and profits which makes it easier to match the two companies and understand the concepts of... If you loss to tolerate a total essay, order it on our website: Ordercustompaper.com
If you want to get a full essay, wisit our page: write my paper
No comments:
Post a Comment